GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Shinyak Corp (XKRX:067290) » Definitions » Cyclically Adjusted FCF per Share

JW Shinyak (XKRX:067290) Cyclically Adjusted FCF per Share : ₩9.96 (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is JW Shinyak Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

JW Shinyak's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩-25.384. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩9.96 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of JW Shinyak was 54.70% per year. The lowest was 13.80% per year. And the median was 16.35% per year.

As of today (2024-06-09), JW Shinyak's current stock price is ₩1795.00. JW Shinyak's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩9.96. JW Shinyak's Cyclically Adjusted Price-to-FCF of today is 180.22.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of JW Shinyak was 1520.59. The lowest was 165.02. And the median was 186.24.


JW Shinyak Cyclically Adjusted FCF per Share Historical Data

The historical data trend for JW Shinyak's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Shinyak Cyclically Adjusted FCF per Share Chart

JW Shinyak Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -79.13 -93.73 -49.56 -7.37 12.15

JW Shinyak Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.49 -8.69 1.70 12.15 9.96

Competitive Comparison of JW Shinyak's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, JW Shinyak's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Shinyak's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Shinyak's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where JW Shinyak's Cyclically Adjusted Price-to-FCF falls into.



JW Shinyak Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JW Shinyak's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-25.384/118.8477*118.8477
=-25.384

Current CPI (Mar. 2024) = 118.8477.

JW Shinyak Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -29.500 99.353 -35.288
201409 -3.999 99.608 -4.771
201412 -74.860 99.098 -89.779
201503 12.143 99.720 14.472
201506 -13.627 100.050 -16.187
201509 10.562 100.110 12.539
201512 -65.014 100.220 -77.098
201603 -8.682 100.560 -10.261
201606 33.270 100.790 39.231
201609 31.306 101.460 36.671
201612 -94.053 101.560 -110.063
201703 -61.520 102.850 -71.089
201706 -82.157 102.610 -95.158
201709 49.250 103.490 56.559
201712 -40.761 102.990 -47.037
201803 41.666 104.100 47.569
201806 6.874 104.130 7.846
201809 57.747 105.650 64.961
201812 2.746 104.350 3.128
201903 -31.275 104.490 -35.572
201906 10.044 104.880 11.382
201909 7.142 105.200 8.069
201912 53.895 105.120 60.933
202003 -18.932 105.540 -21.319
202006 -38.943 104.870 -44.134
202009 59.658 106.200 66.763
202012 42.050 105.765 47.251
202103 -22.839 107.357 -25.283
202106 -13.046 107.579 -14.413
202109 104.357 108.759 114.037
202112 83.507 109.676 90.490
202203 -52.859 111.806 -56.188
202206 21.375 114.083 22.268
202209 -0.525 114.831 -0.543
202212 147.905 115.200 152.588
202303 -25.877 116.550 -26.387
202306 -13.811 117.140 -14.012
202309 42.734 119.111 42.639
202312 20.140 118.848 20.140
202403 -25.384 118.848 -25.384

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


JW Shinyak  (XKRX:067290) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

JW Shinyak's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1795.00/9.96
=180.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of JW Shinyak was 1520.59. The lowest was 165.02. And the median was 186.24.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


JW Shinyak Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of JW Shinyak's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Shinyak (XKRX:067290) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2477, Nambusunhwan-ro, Seocho-gu, Seoul, KOR, 137-864
JW Shinyak Corp is a pharmaceutical company. The company produces and provides high-quality medicine and medical supplies needed in dermatology, urology, pediatrics, otolaryngology. The key products include antibiotics, anesthetics, respiratory drugs, urology drugs, cardiovascular drugs, allergy drugs, digestive drugs, anti-inflammatory drugs, antivirals as well as cosmetic products including creams, cleansers, toners, essences, lotions, among others.

JW Shinyak (XKRX:067290) Headlines

No Headlines